Ikarian Capital’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-223,934
Closed -$687K – 174
2022
Q2
$687K Sell
223,934
-100,000
-31% -$611K 0.13% 93
2022
Q1
$2.34M Sell
323,934
-76,066
-19% -$748K 0.31% 60
2021
Q4
$6.55M Buy
+400,000
New +$4.65M 0.98% 28

Other funds holding PRDS

Ikarian Capital's PRDS Position: Q3 2022 in Review

Ikarian Capital sold out of Pardes Biosciences (PRDS) in Q3 2022, closing a stake of 223,934 shares — an estimated $687K sold.

Ikarian Capital first reported a position in PRDS in Q4 2021 and held it in 3 quarters. The position peaked at $6.55M in Q4 2021. 68 funds tracked by Wall St. Rank hold PRDS as of Q3 2022.

  • Ikarian Capital reported no remaining Pardes Biosciences position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 223,934 Pardes Biosciences shares in Q3 2022, an estimated $687K.
  • Ikarian Capital first reported a position in Pardes Biosciences in Q4 2021 and held it in 3 quarters.
  • Ikarian Capital's Pardes Biosciences position peaked at $6.55M in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Pardes Biosciences as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.